Pharma: Other News To Note
Tuesday, February 14, 2012
Merck & Co. Inc., of Whitehouse Station, N.J., said the FDA approved Zioptan (tafluprost ophthalmic solution) 0.0015 percent, a preservative-free prostaglandin analogue ophthalmic solution for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.